FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc., enabling changes to its labeling or indication under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)